A single plan, a sublingual route for the needle-averse, and a billing cycle that quietly bills thirteen times a year.
- Semaglutide$229/mo
- Tirzepatide$299/mo
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- $229/mo (billed every 28 days, compounded)
- Tirzepatide
- $299/mo (billed every 28 days, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
Goldspan Health scored on our six published factors. See the methodology.
What we like
- One plan per molecule rather than a tiered ladder, so there is no prepay figure pretending to be a monthly rate
- Sublingual full-dose and microdose programs are sold alongside the injections for anyone avoiding needles
- The compounding class is disclosed as 503A or 503B on the therapy pages
- Three clinicians are named on the storefront that delivers the care, with their roles stated
- Prices are published before any account is created, and the renewal timeline is shown as a dated schedule
The caveats
- The hero prints a monthly price while the plan card says the order renews every 28 days — thirteen charges a year against a figure a reader will read as twelve
- Pause, delay and cancel at any time is promised on the storefront while the refund policy says all sales are final and the platform's own terms say a placed order cannot be canceled
- The seal displayed on the storefront certifies the storefront operator's own domain, not this brand's, so it is not evidence about Goldspan
- The homepage claims 50 states while the Terms say some therapies are unavailable in certain states, and which therapies in which states is never said
- Goldspan publishes no legal entity, address or governing law of its own, names no pharmacy, and its clinicians are attributed to a platform that says it is not a medical practice
The verdict
Best for: Someone who wants one plan rather than a ladder, and will read the renewal timeline before subscribing.
Ranked #134 of 548 providers we have reviewed — for comparison, read our CoreAge Rx review, ranked #1. In the ranking it sits between Get Thin MD at #133, 71/100 above and TrimRx at #135, 71/100 below, with the AlyveRx write-up the next one down.
If that review leaves you undecided, the 7 programs we rank against Goldspan Health are graded on the same six factors and listed in score order. If you would rather start from the top of the field, our full board of 548 providers is the place to start if you are still shortlisting. We have also compared it head to head: CoreAge Rx vs Goldspan Health goes to CoreAge Rx, 94/100 to 71/100.
Compare Goldspan Health
Compare with other providers
The closest reviews to Goldspan Health by Verdict Score — the realistic shortlist if you are weighing this one up.
- #147TeleHealth Weight Solutions— TeleHealth Weight Solutions (branded Medi Health Clinics) is a nurse-practitioner-managed telehealth program prescribing compounded semaglutide and tirzepatide for weight loss, shipped with supplies from…71/100
- #148Tru2u— Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.71/100
- #149Voxy— Voxy is a Scottsdale, Arizona telehealth practice offering compounded semaglutide and tirzepatide alongside NAD+ and sermorelin.71/100
- #150Oak— One price at every dose and no membership fee — but Oak publishes nine different "starting" prices, attaches a billing term to none of them, and will not name a rate until you have finished a 29-question intake.68/100
- #151MyDrHank— A six-shelf prescription telehealth catalog advertising compounded GLP-1s from $171 to $240 a month — but no page says which plan length those prices need, and the full price list stays hidden until you give a mobile number.68/100
- #152SkinnyRx— Sells compounded semaglutide and tirzepatide as a weekly shot or a daily tablet, with first-month prices on its home page — but no public page prints what month two costs.68/100
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.